Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients Caregivers Providers
Log In Ask a Question
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Dermatology

Decoding Your Pathology Reports

At a Glance

Bullous Pemphigoid is diagnosed using a combination of skin biopsies and blood tests. The gold standard is a Direct Immunofluorescence (DIF) test showing Linear IgG or C3. Blood tests for anti-BP180 and anti-BP230 antibodies help confirm the diagnosis and monitor disease severity.

A diagnosis of Bullous Pemphigoid (BP) is not made with a single glance; it requires a combination of clinical observation, skin samples (biopsies), and specialized blood work [1][2]. Understanding these reports can help you feel more in control of your care.

The Gold Standard: Direct Immunofluorescence (DIF)

The most important test for confirming BP is Direct Immunofluorescence (DIF). To perform this, a doctor takes a small biopsy of your skin—ideally from the red, itchy area next to a blister (perilesional skin) rather than the blister itself [3].

In the lab, the skin is treated with a special dye that glows under UV light if certain proteins are present.

  • Linear IgG: This means the lab found Immunoglobulin G (antibodies) lined up in a straight line along the basement membrane of your skin [3][4].
  • Linear C3: This indicates Complement 3, a protein that “flags” your tissue for an immune attack, is also deposited in that same linear pattern [5][6].

A result showing “Linear IgG and/or C3” is a hallmark sign of Bullous Pemphigoid [3][7].

Blood Testing: ELISA for BP180 and BP230

While a biopsy looks at the skin, an ELISA (Enzyme-Linked Immunosorbent Assay) test looks at your blood for the specific antibodies causing the trouble [8].

  • Anti-BP180: This measures the antibodies attacking the “bridge” protein between skin layers. High levels of these antibodies often correlate with more severe disease and more active blistering [9][8].
  • Anti-BP230: This measures antibodies against the internal cell protein. While helpful for diagnosis, these levels do not always match how severe your symptoms feel [9].

Advanced Tools: IIF and Salt-Split Skin

If the standard tests are unclear, your doctor may use Indirect Immunofluorescence (IIF). This test uses your serum (blood) to see if your antibodies will attack a “test” skin sample in the lab [10].

One variation is the Salt-Split Skin (SSS) test. The lab uses a salt solution to intentionally separate a piece of test skin between its two layers [10][11].

  • If your antibodies stick to the roof (epidermis) of the split, it points toward Bullous Pemphigoid [12][11].
  • If they stick to the floor (dermis), it may suggest a different condition, like Epidermolysis Bullosa Acquisita (EBA) [13].

Your Pathology Checklist (In Plain English)

When you receive your lab results, look for these specific data points:

  • [ ] Histopathology (Skin Biopsy): Does the report mention a “subepidermal split” (the skin layers separated) or “eosinophils” (allergy-type white blood cells)? [14][15]
  • [ ] DIF Result (Glow Test): Does it specify “Linear IgG” or “Linear C3” (antibodies lined up) along the basement membrane zone? [3][5]
  • [ ] ELISA Levels (Blood Test): Are there numerical values for Anti-BP180 and Anti-BP230 antibodies? [8][16]

Common questions in this guide

What is a Direct Immunofluorescence (DIF) test for Bullous Pemphigoid?
A DIF test is the gold standard method for confirming Bullous Pemphigoid. A doctor takes a small skin biopsy next to a blister and treats it with a dye that glows under UV light to reveal specific antibodies attacking your skin.
What does 'Linear IgG' on my pathology report mean?
Linear IgG means that immunoglobulin G antibodies were found lined up in a straight line along the basement membrane of your skin. This pattern is a classic hallmark sign of Bullous Pemphigoid on a biopsy.
What do high anti-BP180 levels mean?
Anti-BP180 levels measure the antibodies attacking the connections between your skin layers. High levels of these antibodies usually indicate a more severe disease with more active blistering.
What is a salt-split skin test?
A salt-split skin test separates a sample of test skin into two layers using a salt solution. If your blood's antibodies stick to the top layer (the roof) of the split, it strongly points toward a Bullous Pemphigoid diagnosis.
Can steroid treatments affect my biopsy results?
Prior treatments like topical or oral steroids can suppress your immune system and potentially affect the results of your biopsy or blood work. It is important to tell your doctor about any medications you used before testing.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What was the specific pattern of antibody deposition seen on my DIF test?
  2. 2.Was my biopsy taken from perilesional skin (the skin next to a blister), or from the blister itself?
  3. 3.If a salt-split skin test was performed, did the antibodies bind to the 'roof' or the 'floor'?
  4. 4.What are my current BP180 and BP230 antibody levels, and how do these results compare to the reference range?
  5. 5.Will we be re-testing my BP180 levels to monitor how I am responding to treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Reflectance confocal microscopy and optical coherence tomography for the diagnosis of bullous pemphigoid and pemphigus and surrounding subclinical lesions.

    Mandel VD, Cinotti E, Benati E, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2018; (32(9)):1562-1569 doi:10.1111/jdv.14795.

    PMID: 29341355
  2. 2

    Subepithelial autoimmune blistering dermatoses: Clinical features and diagnosis.

    Montagnon CM, Tolkachjov SN, Murrell DF, et al.

    Journal of the American Academy of Dermatology 2021; (85(1)):1-14 doi:10.1016/j.jaad.2020.11.076.

    PMID: 33684496
  3. 3

    Diagnostic value of immunohistochemistry on formalin-fixed, paraffin-embedded skin biopsy specimens for bullous pemphigoid.

    Glauser S, Rutz M, Cazzaniga S, et al.

    The British journal of dermatology 2016; (175(5)):988-993 doi:10.1111/bjd.14686.

    PMID: 27105821
  4. 4

    Basement membrane zone IgE deposition is associated with bullous pemphigoid disease severity and treatment results.

    Kamata A, Kurihara Y, Funakoshi T, et al.

    The British journal of dermatology 2020; (182(5)):1221-1227 doi:10.1111/bjd.18364.

    PMID: 31330562
  5. 5

    From Molecular Insights to Clinical Perspectives in Drug-Associated Bullous Pemphigoid.

    de Nicolas-Ruanes B, Ballester-Martinez A, Garcia-Mouronte E, et al.

    International journal of molecular sciences 2023; (24(23)) doi:10.3390/ijms242316786.

    PMID: 38069109
  6. 6

    A case of bullous pemphigoid induced by torsemide.

    Wurtz P, Borucki R, Georgesen C

    JAAD case reports 2022; (26()):95-97 doi:10.1016/j.jdcr.2022.06.023.

    PMID: 35942352
  7. 7

    Evidence for a role of eosinophils in blister formation in bullous pemphigoid.

    de Graauw E, Sitaru C, Horn M, et al.

    Allergy 2017; (72(7)):1105-1113 doi:10.1111/all.13131.

    PMID: 28135772
  8. 8

    Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.

    Emtenani S, Yuan H, Lin C, et al.

    The British journal of dermatology 2019; (180(5)):1099-1106 doi:10.1111/bjd.17313.

    PMID: 30315657
  9. 9

    A Cross-Sectional Study to Correlate Disease Severity in Bullous Pemphigoid Patients with Serum Levels of Autoantibodies Against BP180 and BP230.

    Muhammed N, Korgaonkar S, Pradhan V, Khopkar US

    Indian dermatology online journal 2021; (12(5)):696-700 doi:10.4103/idoj.IDOJ_813_20.

    PMID: 34667755
  10. 10

    The use of BIOCHIP mosaics in diagnostics of bullous pemphigoid: Evaluation and comparison to conventional multistep procedures.

    Adaszewska A, Kalińska-Bienias A, Jagielski P, et al.

    Journal of cutaneous pathology 2020; (47(2)):121-127 doi:10.1111/cup.13591.

    PMID: 31603994
  11. 11

    Epidermolysis bullosa acquisita: the most frequent pemphigoid disease in patients with dermal binding autoantibodies by indirect immunofluorescence microscopy on human salt-split skin in Tehran, Iran.

    Daneshpazhooh M, Fazlolahi S, Mahmoudi H, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(6)):e370-e372 doi:10.1111/jdv.17137.

    PMID: 33497481
  12. 12

    Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.

    Meijer JM, Diercks GFH, de Lang EWG, et al.

    JAMA dermatology 2019; (155(2)):158-165 doi:10.1001/jamadermatol.2018.4390.

    PMID: 30624575
  13. 13

    Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.

    Goyal N, Rao R, Shenoi SD, et al.

    Indian journal of dermatology, venereology and leprology 2017; (83(5)):550-555 doi:10.4103/ijdvl.IJDVL_678_16.

    PMID: 28749386
  14. 14

    Spongiform pemphigoid: A case series of an uncommon histopathologic pattern.

    Merton A, Wu YH

    Journal of cutaneous pathology 2020; (47(4)):339-345 doi:10.1111/cup.13627.

    PMID: 31837162
  15. 15

    Dyshidrosiform Bullous Pemphigoid Triggered by COVID-19 Vaccination.

    Shanshal M

    Cureus 2022; (14(6)):e26383 doi:10.7759/cureus.26383.

    PMID: 35911257
  16. 16

    Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study.

    Dikmen HO, Yilmaz K, Benoit S, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2022; (36(11)):2181-2189 doi:10.1111/jdv.18414.

    PMID: 35796163

This page explains Bullous Pemphigoid pathology terminology for educational purposes only. Always rely on your dermatologist or pathologist to interpret your specific lab results and guide your treatment.

Get notified when new evidence is published on Bullous pemphigoid.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.